D. E. Shaw & Co., Inc. Cytek Biosciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$8.44 - $13.47 $476,269 - $760,112	-56,430 Reduced 29.75%	133,249 $1.22 Million
Q4 2022 Feb 14, 2023	BUY	$9.71 - $15.86 $992,031 - $1.62 Million	102,166 Added 116.74%	189,679 $1.94 Million
Q3 2022 Nov 14, 2022	SELL	$10.96 - $15.45 $1.35 Million - $1.9 Million	-123,289 Reduced 58.49%	87,513 $1.29 Million
Q2 2022 Aug 15, 2022	SELL	$7.41 - $11.56 $3.88 Million - $6.05 Million	-523,254 Reduced 71.28%	210,802 $2.26 Million
Q1 2022 May 16, 2022	BUY	$9.89 - $17.25 $7.1 Million - $12.4 Million	718,217 Added 4534.48%	734,056 $7.91 Million
Q4 2021 Feb 14, 2022	BUY	$16.14 - $25.04 $255,641 - $396,608	15,839 New	15,839 $258,000

134

71.7M

400

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $851M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.